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ver Veterans Administration Hospital with 234 
homo grafts in 216 patients. Ureteroneocystos-
tomy was performed in 178 instances with post-
operative difficulties in 16 (9 per cent). Recon-
struction by ureteroureterostomy was accom-
plished in 55 instances with urological complica-
tions in 7 (13 percent). Urological complica-
tions were found to be far more life-threatening 
if they occurred during the first 6 weeks after 
transplantation. All 5 deaths directly attributable 
to urological problems occurred in patients who 
developed difficulties during this period. There 
was no mortality attributable to urological com-
plications occurring several months to two and 
a half years after transplantation. The diag-
nosis and management of all urological com-
plications are described and suggestions made, 
based on the authors' experience. The wealth of 
experience described in this article makes it an 
essential part of the bibliography of any urolo-
gist performing renal transplants. 
2. SaJaman, J. R., CaIne, R. Y., Pena, J., Sells, 
R. A., White, H. J. 0., and Yoffa, D.: Surgical 
aspects of clinical renal transplantation. Brit. J. 
Surg. 56:413, 1969. 
The surgical experience, over three years, of 
74 kidney transplants from AddenBrooke's Hos-
pital, Cambridge, is reported. This is an excel-
lent review of the surgical procedures that are 
performed in a transplant unit, their indications, 
complications, etc. Operations include live and 
cadaver donor nephrectomies, recipient nephrec-
tomies, and the various methods of transplant 
employed by this group. Urinary fistulas and 
leaks are described with some interesting re-
constructions. 
3. O'Donoghue, E. P. N., Chisholm, G. D., and 
Shackman, R.: The urological complications of 
transplantation. Proceedings of the European 
Dialysis and Transplant Association 8:252, 1971. 
Reported are 102 transplants, 100 recon-
structed by ureteroneocystostomy and 2 by pri-
mary ureteroileostomy. There were 13 urinary 
fistulas. There were no graft nephrectomies or 
deaths associated with 5 bladder fistulas. Of 5 
patients with ureteral fistulas, 2 died and 1 re-
quired transplant nephrectomy. Two patients 
were managed by a unique method-temporary 
ileo-ureterostomy and subsequent ileouretero-
cystoplasty with excellent resuhs. Three un-
common pyelocaliceal fistulas likewise responded 
well to imaginative surgery-in these cases in-
tact omental flap graft. Of 1 patients with ure-
teric obstruction, only 3 were managed suc-
cessfully. There were also 2 patients with post-
transplant vesicoureteral reflux and persistent 
infection. 
4. Williams, G., Birtch, A. G., Wilson, R. E., 
Harrison, J. H., and Murray, J. E.: Urological 
complications of renal transplantation. Brit. J. 
Urol. 42:21,1970. 
The experience at the Peter Bent Brigham 
Hospital with urinary extravasation in 23 pa-
tients out of 158 transplants is reported. The 
investigators describe the problems associated 
with diagnosing extravasation, as well as their 
methods of managing it. In an attempt to de-
crease the mortality associated with extravasa-
tion, they suggest leaving the wound open for 
drainage as well as proximal nephrostomy. They 
feel that urinary leaks are only rarely success-
fully managed with ureteral catheter drainage. 
Overview of Renal Homotransplantation: 
A Ten-Year Retrospective Study 
Thomas E. Starzl 
It requires only a few moments of reftection 
to appreciate how brief is the history of kid-
ney homotransplantation as a practical means 
of treating people with terminal renal disease. 
With a few historically important exceptions 
recorded by Murray and Merrill, by Ham-
burger, Ktiss, and Schackman, and by Demp-
ster (summarized by Goodwin and MartinI), 
attempts under total body irradiation to use 
renal homotransplantation for clinical therapy 
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before 1962 were doomed to failure. But in 
that year and in 1963, three American2 - 4 and 
one European!i centers acquired experience 
with the drug combination of azathioprine 
and prednisone for the prevention or reversal 
of rejection. Almost immediately, it became 
obvious that major progress had been made 
in the treatment of a failed vital organ system, 
an achievement that had amplified signifi-
cance because of collateral advances in renal 
dialysis technology by which prospective re-
cipients could be resuscitated and maintained 
in preparation for transplantation. At our 
center in 1966, a third potent agent, heter-
ologous antilymphocyte globulin (ALG), was 
added to azathioprine and prednisone in what 
has been termed "a triple drug" immunosup-
pressive program.6 
Groth 7 has described the steps by which 
renal hemotransplantation was brought from 
the state of clinical experimentation to ac-
cepted treatment. No attempt will be made in 
the following discussion to cover that histori-
cal ground. Instead, the objective will be only 
to provide a follow-up on one of the earliest 
groups of kidney patients in which a sub-
stantial number of graft recipients survived 
beyond the early postoperative period, and 
therefore became available for observations 
about the long-term expectations after such 
therapy. Thus, these comments will be con-
cerned almost exclusively with patients treated 
by renal homotransplantation from nine to 
more than ten years ago at the Denver Vet-
erans Administration and Colorado General 
Hospitals. 
CASE MATERIAL 
Sixty-four patients underwent renal homo-
transplantation between November, 1962, and 
early 1964; they provided the basis for a bookS 
on this subject published in 1964. There were 
46 recipients of consanguineous kidneys from 
23 siblings, 20 parents, 1 aunt, 1 uncle, and 
1 cousin, and 18 recipients of nonrelated 
kidneys donated by healthy volunteers. Im-
munosuppression was with azathioprine and 
prednisone, using two regimens. In 45 cases 
azathioprine was started alone; prednisone 
was added in 43 of these 45 patients with the 
appearance of clinically obvious rejection. In 
the other 19 recipients both drugs were ad-
ministered from the outset. 
Typing procedures were not available when 
this series was compiled. Consequently, the 
donor-recipient matching was not by any kind 
of immunological guidelines except for the 
avoidance in all cases after the twenty-third 
one of the kind of red blood cell type incom-
patibility that can (but does not necessarily) 
lead to hyperacute rejection.8 Parenthetically, 
one of our earliest recipients is still alive with 
perfect graft function more than 10 years after 
transplantation from a B+ type donor to A+ 
type recipient, a combination that today 
would be avoided. 
All of the recipients had splenectomy. The 
first 8 (of whom 4 are still living) had thy-
mectomy prior to transplantation. In the 
hope of thereby being able to reduce im-
munosuppression, 9 additional patients had 
thymectomy from U~ to 17 months after 
transplantation. Five of the 9 recipients are 
still alive, but 3 of them have undergone re-
transplantation. Although thymectomy may 
have a subtle but demonstrable effect in hu-
mans,9 it is no longer performed in our center. 
SURVIVAL 
THE 46 RELATED CASES 
After a heavy mortality (33 per cent) in the 
first 6 months, subsequent deaths have been 
uncommon (Fig. 12-1). Thirty-one recipients 
survived for a half year; of these, 29 and 28 
lived for 3 and 5 years respectively, and 24 
are still alive after 9 to lOlA years. Twenty-
one of the 24 have function of their original 
grafts. Two others had retransplantations 51h 
and 53,4 years after the first procedure and the 
secondary kidneys have subsequently func-
tioned for 4;3 and 4~ years. The final pa-
tient had function of his first kidney for 7 
years, followed by four retransplantations in 
the next 21h years. He has a well-functioning 
kidney at present. 
The outcome was not strikingly influenced 
by the nature of the relationship, whether this 
be parental, sibling, or other (Table 12-1). 
The parent-to-offspring results were amaz-
ingly stable in terms of recipient survival. At 
the end of 6 months, 14 of 20 recipients 
(70 per cent) were alive. By 9 to 1l~ years 
there were still 13 (65 per cent) alive, al-
though 3 of these were by virtue of retrans-
plantation. Also of interest was the fact that 
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Fig. 12-1. Life survival curves of 64 patients 
treated from November, 1962, to March, 1964. 
The denominators in the related and nonrelated 
curves refer to patient survival and the numera-
tors to survival of the original homograft. Thus, 
22 of the 26 living recipients still bear their pri-
mary grafts; the other 4 have successful retrans-
plants. 
all of the 3 distantly related renal grafts 
(aunt, uncle, and cousin) were providing su-
perb function nearly a decade after their in-
sertion. (Table 12-1). 
The causes of mortailty in the first 5 years' 
follow-up of this series have been exhaustively 
reported,8.9 for which reason only the 4 
deaths in the second 5 years will be men-
tioned. Two patients with adequate renal 
function U~ and 9 years posttransplantation 
died of chronic aggressive hepatitis of several 
years duration; one was Australia antigen 
positive. A third patient had a fatal myo-
cardial infarction after 7V3 years. The fourth 
patient had a technically unsuccessful retrans-
plantation in the sixth year, and committed 
suicide by refusing to be placed back on 
hemodialysis. 
TIlE 18 NONRELA TED CASES 
Two thirds of the recipients died in the first 
year with a mortality that continued until only 
2 patients were left at the 5-year mark (Fig. 
12-1). These 2 are still alive after more than 
Table 12·1. The Influence of Consanguinity Upon Present Survival in 46 Cases After 9 to 10% Years 
One Year Three Years Five Years Now 
Donor Patient Graft Patient Graft Patient Graft Patient Graft 
20 Parents 14 14 14 14 14 (70%) 14 (70%) 13 (65%)· 10 (50%) 
23 Siblings 14 14 12 12 11 (48%) 11 (48%) 8 (35%) 8 (35%) 
3 aunt, 
uncle or 
cousin 3 3 3 3 3 (100%) 3 (100%) 3 (100%) 3 (100%) 
• Retransplantations were carried out after 51h, 5"*, and 7 years. In the last instance there have been four 
retransplantations in the last 2lh years. 
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been four 
9 years but in the second instance a second 
homograft from a mother has supported life 
for the last 6Y.l years of the total survival. 
GRAFf FUNCTION AND 
IMMUNOSUPPRESSION 
In Table 12-2 are shown the average current 
renal functions of the 26 survivors. These 
values represent the function of 22 primary 
kidneys that have been in place for 9 to lOlA 
years and 4 retransplants that have been in 
place for 2 to 6Y2 years. On the average, the 
original grafts are performing better than the 
recently transplanted ones with lower mainte-
nance doses of the immunosuppressive agents. 
Arterial hypertension is an almost universal 
finding in the immediate posttransplantation 
period and even for several years afterward.8• 9 
This problem has tended to become less with 
longer follow-up. Only the patient with the 
most recent retransplantation has severe hy-
pertension. Five other patients receive small 
daily doses of a combination of antihyperten-
sives. Fourteen of the surviving 26 recipients 
require no antihypertensive therapy, and 6 are 
receiving only chlorothiazide. With the gen-
erally low steroid doses, there are no examples 
of steroid-induced diabetes. 
THE QUESTION OF CANCER 
Six of the 64 recipients (9 per cent), including 
4 who are still alive, have developed skin can-
cers of the face, lip, or arm. Treatment was by 
standard surgical measures. So far cancer has 
not been a cause of death in this original 
group of patients, although we have had 2 
deaths from de novo reticulum cell sarcomas 
in patients treated since 1964.9 
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WAS SURVIVAL WORm 
THE PRICE? 
There has been a remarkable degree of re-
habilitation in this group of surviving recipi-
ents. All of those who were adults at the time 
of transplantation have returned to some kind 
of full-time work. 
Twelve of the present survivors were 
younger than 18 years (3 to 17) at the time 
of the original operation. They all returned 
to school, half graduated from college, 8 now 
support themselves fully in adult work, and 9 
have married. The only one who has spent an 
excessive amount of time in the hospital is a 
child originally treated at the age of 3, whose 
original homograft failed, and who subse-
quently required multiple retransplantations. 
He is now 13 years old and is stunted in 
growth. 
Obviously, from the beginning of our pro-
gram, pediatric recipients have been consid-
ered prime candidate!'! for transplantation 
providing the appropriate variations are made 
in operative technique,8.10 including high vas-
cular anastomoses and the transperitoneal 
route if necessary (Fig. 12-2). This viewll• 12 
was upheld by Williams, Lee, and Hume1S 
and has been confirmed in numerous more re-
cent articles, which are reviewed in Hume's 
commentary earlier in this chapter. In our 
experience, the pediatric patient has not been 
markedly more prone than the adult to re-
current glomerulonephritis, rejection, drug 
toxicity, or any of the complications of homo-
transplantation under immunosuppression. 
At the time of this original series, potential 
recipients were screened with· great care to 
rule out those with possible important psychi-
atric problems. Because of this, it has not 
been surprising to find exceptional emotional 
stability amongst those who were accepted and 
who are still surviving. Excellent adjustments 
Table 12-2. Average Current Renal Function and Immunosuppression (Mean ± S.D.) 
in 26 Recipients of Renal Homografts Surviving 9 to 10Y4 Years 
Posttransplantation (Data Assembled in September. 1972) 
22 Original grafts 
4 Retransplantation· 
All 26 Patients 
BUN 
(mg%) 
19.8 ± 8.3 
39.0 ± 18.5 
22.7 ± 12.2 
Serum 
Creatinine 
(mg%) 
1.3 ± O.S 
1.9 ± 0.8 
1.4 ± 0.6 
Creatinine 
Clearance 
(ml/min) 
80.4 ± 22.9 
60.0 ± 33.4 
77.3 ± 25.2 
Azathioprine 
(mglday) 
121.0 ± 38.8 
82.5 ± 56.8 
115.1 ± 43.1 
Prednisone 
(mg/day) 
8.1 ± 6.3 
20.0 ± 7.1 
9.9 ± 7.7 
• Patients surviving 2 to 61-2 years after retransplantation. 
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Fig. 12-2. A technique that permits the trans-
plantation of adult homografts to infants or 
small children. The essential feature is "high" 
anastomoses of the renal vessels to the vena cava 
and the aorta or iliac artery. The entire opera-
tion can be performed tarnsperitoneally through 
a midline incision with mobilization of the as-
cending colon as shown. Alternatively the retro-
peritoneal route may be selected in children of 
intermediate size, developing the extra peritoneal 
space through either a midline or a long oblique 
lower abdominal incision. (By permission of 
Surg. Gynec. Obstet.1l9:106, 1964.) 
have been made in spite of such serious eady 
postoperative complications as aseptic necro-
sis of one or both of the femoral heads in 3 
of the adolescents. 8 These latter patients have 
learned to walk adequately in spite of their 
handicaps. Many of the young patients were 
stunted in growth before and after their trans-
plantations and have had catch-up growth 
spurts late in their teens. Before concluding 
that catch-up growth will not occur, a fol-
low-up period of 5 to 10 years may be 
necessary, as Lilly et a1.12 have emphasized 
from a study of our cases. Consequently, we 
have been far less pessimistic about this pos-
sibility than both Najarian et a1. 14 and Hume 
(Fig. 12-3). Even so, it is prudent to warn 
the parents of a pediatric recipient about the 
possibility of growth retardation. 
Nine of the 64 patients of the original 
series have had children of their own, in-
cluding 3 by 2 female and 10 by 7 male 
recipients. One of these offspring had a 
meningomyelocele which required surgical 
correction. It is of interest that all the chil-
dren issuing from this transplant population 
came from 26 still surviving. Thus, no or-
phans have so far been created by the prema-
ture death of a transplant patient. 
URINARY RECONSTRUCTION 
To permit consistent success after renal trans-
plantation, well-known urological pt:0cedures 
were adapted and refined. In our first 64 
cases, ureteroneocystostomy of the Paquin-
Marshall nipl?le and tunnel varietyl& was used 
to reconstitute the urinary tract. 8. 16 The cys-
totomy through which the ureter implantation 
was performed was a small one. Pains were 
taken to ensure watertight anastomoses and 
cystotomy closures employing fine suture ma-
terials and exercising meticulous technique. 
Because of these precautions, it was found un-
necessary to drain the wounds, to place supra-
pubic cystotomy tubes, or to leave stents. 
Thus, this important aspect of the technical 
procedure of transplantation was taken from 
urology, improved because of the special 
needs of the immunosuppressed patient, and 
later brought back as a series of refinements 
into the standard modern operative urology 
as applied to non transplant patients. 
With ureteroneocystotomy in these early 
cases, complications occurred at an incidence 
of approximately 10 per cent, consisting 
mostly of anastomotic strictures.IS If these oc-
curred early in the postoperative course, sec-
ondary repair proved to be dangerous. On the 
other hand, if these reoperations were done 
after 6 weeks, conversion to ureteroureteros-
tomy or ureteropyelostomy was possible with-
out mortality. The latest complication of 
ureteroneocystostomy in our experience oc-
curred at 3 years. From then onward to as 
long as 10 years no further difficulties have 
been encountered. 
In a later series of cases treated from 1964 
to 1966, ureteroureterostomy was performed 
as the primary operation.16 This practice car-
ried a complication incidence of approxi-
mately 10 per cent, consisting mainly of anas-
tomotic urinary fistula from which there were 
two deaths. There were no strictures. 
Although life-threatening complications in 
our early experience were observed with ap-
proximately equal frequency after both pro-
t 
1 
I 
~ 
! surgical 
the chil-
>opulation 
IS, no or-
he prema-
;nal trans- I lrocedures :; 
r first 64 
, 
, 
! Paquin-
; was used 
; The cys-
plantation 
ains were 
loses and 
uture ma-
iechnique, 
found un-
lce supra-
ve stents. 
technical 
tken from 
Ie special 
tient, and 
:finements 
e urology 
lese early 
incidence 
consisting 
f these oc-
>urse, sec-
1S. On the 
.vere done 
oureteros-
;ible with-
cation of 
°ience oc-
:ard to as 
lties have 
·rom 1964 
performed 
lctice car-
approxi-
y of anas-
here were 
cations in 
I with ap-
both pro-
200 
180 
E 160 
2 
.... S 140 
w 
:r:: 
120 
4 
cedures, it is our opinion, in support of 
that expressed earlier in this chapter in 
Burne's commentary, that ureteroneocystos-
tomy should usually be the first choice, par-
ticularly since its presertt-day complication 
rate is more like 3 per cent than the 10 per cent 
figure in Prout's original report17 and in our 
own. 8•16 It requires less technical finesse for 
its performance than ureteroureterostomy or 
ureteropyelostomy. It has a very low inci-
dence of the dangerous complication of uri-
nary fistula. Finally, the procedure ensures 
preservation of a long segment of homograft 
ureter for later anastomosis to the patient's 
retained ureters should that become necessary 
either early or late after transplantation. 
Whatever the relative merits of these vari-
ous techniques, it is scarcely debatable that 
the urologist or surgeon interested in renal 
transplantation should have the skill to carry 
out anyone of the alternative methods under 
the appropriate circumstanceso For example, 
if the homograft ureter is too short at the 
time of the initial operation, the only feasible 
solution may be with ureteroureterostomy or 
ureteropyelostomy. Moreover, as mentioned 
earlier, the latter procedures have been of the 
utmost importance in treating complications 
after successful first operations. 
PERSPECTIVE FROM EARLY CASES 
It is axiomatic that some degree of immuno-
logical weakening must be accepted as the 
price of success after whole organ transplan-
6 
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Fig. 12-3. The height percentile growth curve 
in a lO-year-old girl who was far below the third 
percentile at the time of renal homotransplan-
tation. After operation, steroids were gradually 
tapered. She did not reach the 50th height per-
centile until more than 5 years after surgery. 
(By permission of Pediatrics, 47: 548, 1971.) 
tation under immunosuppression. Because of 
this, it was once feared that a real margin of 
safety might not exist which would permit 
effective graft protection without killing the 
host. The fallacy of this assumption as it ap-
plies to the early postoperative course has 
long since been proved. Now there is evidence 
that immunosuppression may be tolerated for 
intervals that will extend beyond a decade in 
many instances. 
In the early days of transplantation, the 
feared specter with chronic immunosuppres-
sion therapy was infection, particularly with 
opportunistic organisms for which effective 
treatment is not available. A second concern 
has more recently derived from the well-
documented increased incidence of de novo 
malignancy in the transplant population. Both 
anxieties have a real basis as the observations 
in this early series have shown. Yet, the inci-
dence and severity of late infection or tumors 
have by no means cancelled the effectiveness 
of treatment by transplantation. 
Instead, with each passing year the case is 
strengthened that transplantation represents 
one of the greatest, although as yet incom-
pletely exploited, therapeutic achievements 
of modern medicine. It has become clear that 
about half of our original series of related 
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kidney recipients are going to move into the 
second decade of their convalescence. The 
poorer results in nonrelated transplantation 
would have been discouraging if it were not 
for the great progress made in many centers 
(see below), including our own with cadav-
eric transplantation, since the spring of 1964, 
when the presently reported series was com-
pleted. 
SUBSEQUENT DEVELOPMENTS 
As mentioned in the introduction, heterolo-
gous ALG was introduced clinically in 1966 
as an adjuvant to azathioprine and prednisone 
during the critical early posttransplantation 
period. 6 Even more recently, we have given 
the alkylating agent cyclophosphamide an ex-
tensive and successful trial in replacement of 
azathioprine. IS These clinical investigations 
have shown that a variety of multi drug im-
munosuppressive regimens can be used to 
achieve the desired result after transplanta-
tion and have indicated the feasibility and de-
sirability of continuing to search for new 
therapeutic approaches. Since 1964 and using 
different treatment programs, the one-year 
success rate after consanguineous transplanta-
tion has risen in many centers to more than 
85 per cent. After cadaveric transplantation, 
a reasonable one-year kidney survival rate is 
65 per cent. 
It is disappointing to relate that exploita-
tion of HL-A typing in donor-recipient pair-
ing has not had a more prominent role in this 
improved survival. Strong correlations be-
tween the quality of HL-A matching and the 
clinical outcome have been documented for 
most transplantation centers only with per-
fectly matched siblings.9 However, tissue typ-
ing techniques do permit the identification of 
states of presensitization by the d<rtection in 
the recipient serum of cytotoxic antibodies 
with antigraft specificity. Because there is a 
high incidence of hyperacute rejection of the 
homograft under this circumstance, transplan-
tation is usually avoided.19 
From a practical point of view, one of the 
most revolutionary developments in transplan-
tation in the past 5 years has been Belzer's 
technique20 of preserving excised kidneys in 
an extracorporeal perfusion system primed 
with altered plasma. The reliability of this 
method has converted cadaveric renal trans-
plantation from an urgent and invariably 
inconvenient undertaking with inevitable wast-
age of organs to an elective and highly effi-
cient one. 
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